A phase 1/2 study investigating intraprostatic anti-CTLA-4 and PD-1 blockade, plus radiation and ADXS-PSA in metastatic prostate cancer
Phase of Trial: Phase I/II
Latest Information Update: 01 Dec 2015
At a glance
- Drugs ADXS 31142 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms CARAVAN
- 01 Dec 2015 According to the Advaxis Inc. media release, FDA has placed ADXS- PSA trials on clinical hold.
- 01 Dec 2015 Status changed from planning to suspended, according to the Advaxis Inc. media release.
- 07 Aug 2015 New trial record